We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$677M
AUM Growth
+$47.9M
Cap. Flow
+$18.7M
Cap. Flow %
2.77%
Top 10 Hldgs %
30.54%
Holding
223
New
55
Increased
84
Reduced
41
Closed
38

Top Buys

Rank Stock Value
1
ROP icon
Roper Technologies
ROP
+$9.04M
2
COST icon
Costco
COST
+$8.69M
3
ED icon
Consolidated Edison
ED
+$3.04M
4
PG icon
Procter & Gamble
PG
+$2.75M
5
HRL icon
Hormel Foods
HRL
+$2.2M

Sector Composition

Rank Sector Weight
1 Technology 14.06%
2 Healthcare 12.64%
3 Consumer Staples 11.38%
4 Financials 9.76%
5 Communication Services 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
151
Sarepta Therapeutics
SRPT
$1.57B
$321K 0.05%
4,312
+2,370
+122% +$219K
NVTA
152
DELISTED
Invitae Corporation
NVTA
$321K 0.05%
8,405
-4,172
-33% -$190K
BYND icon
153
Beyond Meat
BYND
$292M
$318K 0.05%
+2,446
New +$360K
CELH icon
154
Celsius Holdings
CELH
$7.47B
$318K 0.05%
+19,881
New +$373K
QTRX icon
155
Quanterix
QTRX
$164M
$318K 0.05%
+5,435
New +$367K
PLAN
156
DELISTED
Anaplan, Inc.
PLAN
$318K 0.05%
5,909
+1,095
+23% +$73.8K
RARE icon
157
Ultragenyx Pharmaceutical
RARE
$2.45B
$315K 0.05%
+2,768
New +$377K
LULU icon
158
lululemon athletica
LULU
$13.5B
$314K 0.05%
1,023
+72
+8% +$23.6K
CHRS icon
159
Coherus Oncology
CHRS
$217M
$313K 0.05%
+21,429
New +$364K
ESGE icon
160
iShares ESG Aware MSCI EM ETF
ESGE
$6.58B
$312K 0.05%
7,213
ROKU icon
161
Roku
ROKU
$21.5B
$311K 0.05%
955
-869
-48% -$341K
TWST icon
162
Twist Bioscience
TWST
$5.7B
$311K 0.05%
+2,507
New +$381K
CYRX icon
163
CryoPort
CYRX
$761M
$309K 0.05%
+5,938
New +$361K
PTCT icon
164
PTC Therapeutics
PTCT
$5.68B
$308K 0.05%
+6,499
New +$386K
RGNX icon
165
Regenxbio
RGNX
$620M
$307K 0.05%
+9,008
New +$384K
VGLT icon
166
Vanguard Long-Term Treasury ETF
VGLT
$10B
$300K 0.04%
3,627
+1,077
+42% +$95.1K
TENB icon
167
Tenable Holdings
TENB
$3.6B
$299K 0.04%
+8,270
New +$374K
VCLT icon
168
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$298K 0.04%
2,939
+467
+19% +$48.9K
ESTC icon
169
Elastic
ESTC
$6.84B
$287K 0.04%
+2,585
New +$367K
KPTI icon
170
Karyopharm Therapeutics
KPTI
$43.5M
$284K 0.04%
+1,802
New +$380K
ILMN icon
171
Illumina
ILMN
$31B
$281K 0.04%
752
+25
+3% +$10.2K
NEE icon
172
NextEra Energy
NEE
$181B
$277K 0.04%
3,666
+242
+7% +$18.9K
IRTC icon
173
iRhythm Holdings
IRTC
$3.85B
$275K 0.04%
1,979
-631
-24% -$113K
VNQ icon
174
Vanguard Real Estate ETF
VNQ
$39.2B
$275K 0.04%
2,998
+423
+16% +$37.2K
RAMP icon
175
LiveRamp
RAMP
$2.3B
$271K 0.04%
+5,219
New +$356K

Similar funds

Spearhead Capital Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Spearhead Capital Advisors held 223 positions worth $677M, up 7.6% from $629M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q1 2021 filing shows 55 new, 84 increased, 41 reduced and 38 closed positions. Its largest new stake was Roper Technologies: 22,529 shares worth $9.09M. The largest sale was AT&T, an estimated $9.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q1 2021 buy was Roper Technologies: 22,529 shares worth $9.09M.
  • Spearhead Capital Advisors added most to Costco in Q1 2021, an estimated $8.69M increase.
  • Spearhead Capital Advisors's biggest Q1 2021 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $4.49M.
  • Spearhead Capital Advisors fully exited AT&T in Q1 2021, selling an estimated $9.9M.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $677M portfolio in Q1 2021.
  • Spearhead Capital Advisors opened 55 new positions and closed 38 in Q1 2021.
  • Spearhead Capital Advisors's portfolio value rose 7.6% quarter-over-quarter to $677M.

Based on Spearhead Capital Advisors's 13F filing for Q1 2021, filed 28 Apr 2021.